HORMONE PROFILES AND THEIR RELATION WITH MENSTRUAL CYCLES IN PATIENTS UNDERGOING HEMODIALYSIS

Basit Öğe Kaydı
dc.contributor.authorArikan, Deniz Cemgil
dc.contributor.authorBozkurt, Serpil
dc.contributor.authorArikan, Ilker
dc.contributor.authorTurgut, Emre
dc.date.accessioned2024-07-12T21:38:05Z
dc.date.available2024-07-12T21:38:05Z
dc.date.issued2011en_US
dc.department[Belirlenecek]en_US
dc.description.abstractObjective: To investigate the etiology of menstrual disorders among patients undergoing hemodialysis due to chronic renal failure by assessing menstrual history, serum hormone levels and other biochemical factors. Material and methods: Thirty patients undergoing hemodialysis and 30 healthy women at reproductive age were enrolled in our study. Demographic characteristics, hormonal and biochemical data, sonographically measured endometrial thickness values of the subjects were compared. In addition, the present and the pre-hemodialysis menstrual pattern of the patients undergoing hemodialysis were recorded. The hormonal, hematological and biochemical data of the patients were compared according to their menstrual patterns. Results: No statistical significance was seen between age, BMI, gravida, parity, abortion and curettage among groups (p>0.05). Hemoglobin and hematocrit levels were significantly lower in the hemodialysis group than in the control (p<0.05). Although serum FSH levels were higher and estradiol levels were lower in the hemodialysis group, these differences were not statistically significant (p>0.05). Mean serum LH and prolactin levels were significantly higher in the hemodialysis group compared to the control (p<0.05). No statistically significant difference was noted for endometrial thickness between the groups (p>0.05). Serum LH and prolactin levels were higher and serum FSH, estradiol and TSH levels were lower in patients who developed amenorrhea after hemodialysis treatment when compared to non-amenorrheic subjects. However, these differences were not statistically significant (p>0.05). Discussion: The most important factor in the etiology of menstrual disorders seen in chronic renal failure patients was high serum LH and prolactin levels. Hemodialysis is a successful treatment that extends life expectancy and ameliorates the hypothalamo-pituitary-ovarian axis in chronic renal failure patients.en_US
dc.identifier.doi10.5505/tjod.2011.80378
dc.identifier.endpage39en_US
dc.identifier.issn2149-9322
dc.identifier.issn2149-9330
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-78651400010en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage32en_US
dc.identifier.urihttps://doi.org/10.5505/tjod.2011.80378
dc.identifier.urihttps://hdl.handle.net/20.500.12415/7062
dc.identifier.volume8en_US
dc.identifier.wosWOS:000422507700004en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoenen_US
dc.publisherGalenos Yayinciliken_US
dc.relation.ispartofTurkish Journal of Obstetrics And Gynecologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzKY04498
dc.subjectChronic Renal Failureen_US
dc.subjectHemodialysisen_US
dc.subjectMenstrual Disturbancesen_US
dc.subjectHormone Profilesen_US
dc.titleHORMONE PROFILES AND THEIR RELATION WITH MENSTRUAL CYCLES IN PATIENTS UNDERGOING HEMODIALYSISen_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu